Cerebral salt-wasting syndrome (CSWS) has been regarded as a misnomer of th
e syndrome of inappropriate secretion of antidiuretic hormone (SIADH). We t
ake the position that CSWS does exist and might be more common than SIADH,
Differentiation between groups has been difficult because of overlapping si
gns, symptoms, and associated diseases. Euvolemia in SIADH and hypovolemia
in CSWS may be the only contrasting variables. However, clinical assessment
of extracellular volume is accurate in about 50% of these patients. Determ
ination of serum urate and fractional excretion rates of urate can differen
tiate one group from the other. In both groups, hyponatremia coexists with
hypouricemia and increased fractional excretion of urate, When the hyponatr
emia is corrected by water restriction, hypouricemia and elevated FEurate c
orrect in SIADH but persist in CSWS. Persistent hypouricemia and elevated F
Eurate were commonly noted with pulmonary and/or intracranial diseases. The
absence of intracranial diseases in some patients suggests that renal salt
wasting might be a more appropriate term than CSWS, A review of renal/CSWS
reveals three studies involving hyponatremic neurosurgical patients who ha
d decreased blood volume, decreased central venous pressure, and inappropri
ately high urinary sodium concentrations in the majority of them, suggestin
g that CSWS was more common than SIADH in neurosurgical patients. Evidence
for the presence of a plasma natriuretic factor in CSWS is presented.